Slow channel calcium antagonists in the treatment of supraventricular tachycardia (Q40104127)

17 September 2017

1 reference

title

Slow channel calcium antagonists in the treatment of supraventricular tachycardia (English)

1 reference

Cardiology and cardiovascular medicine

17 September 2017

main subject

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

22 August 2023

author name string

J. V. Talano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6180453

22 August 2023

C. Tommaso

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6180453

22 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6180453

22 August 2023

publication date

1 September 1982

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0033062082900251?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

https://api.elsevier.com/content/article/PII:0033062082900251?httpAccept=text/plain

22 August 2023

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Progress in Cardiovascular Diseases

22 August 2023

published in

1 reference

17 September 2017

volume

25

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

141-156

1 reference

Ionic basis of electrical activity in cardiac tissues

17 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Sodium-calcium exchange in regulation of cardiac contractility. Evidence for an electrogenic, voltage-dependent mechanism

22 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. I. Pattern of inotropic effects of the racemic compounds

22 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Effects of agents which inhibit the slow channel on sinus node automaticity and atrioventricular conduction in the dog.

22 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

The effects of nifedipine on contraction and monophasic action potential of isolated cat myocardium

22 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Effects of atrio-ventricular conduction of calcium-antagonistic coronary vasodilators, local anaesthetics and quinidine injected into the posterior and the anterior septal artery of the atrio-ventricular node preparation of the dog.

22 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study

22 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Effect of verapamil on the noraml action potential and on a calcium-dependent slow response of canine cardiac Purkinje fibers

22 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Action potentials, afterpotentials, and arrhythmias

22 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Triggered activity in cardiac muscle fibers of the simian mitral valve

22 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Ultrastructure and transmembrane potentials of cardiac muscle in the human anterior mitral valve leaflet

22 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Electrophysiological studies on the mechanism of electrically induced sustained rhythmic activity in the rabbit right atrium

22 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Triggered and automatic activity in the canine coronary sinus

22 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Initiation of Sustained Rhythmic Activity by Single Propagated Action Potentials in Canine Cardiac Purkinje Fibers Exposed to Sodium-Free Solution or to Ouabain

22 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Immediate effects of intravenous verapamil on atrial fibrillation

22 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Verapamil in the treatment of paroxysmal supraventricular tachycardia

22 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Effect of verapamil on normal sinoatrial node function and on sick sinus syndrome

22 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Action of verapamil on sinus node, atrioventricular, and intraventricular conduction

22 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia

22 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome

22 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Concealed bypasses of the atrioventricular node in patients with paroxysmal supraventricular tachycardia revealed by intracardiac electrical stimulation and verapamil

22 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Effect of verapamil on the sinoatrial and atrioventricular nodes of the rabbit and the mechanism by which it arrests reentrant atrioventricular nodal tachycardia

22 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function

22 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study

22 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Verapamil induced premature ventricular beats before reversion of supraventricular tachycardia

22 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Electrocardiographic observations on the termination of supraventricular tachycardia by verapamil

22 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

The use of beta-adrenergic receptor blocking drugs in dysrhythmias

22 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Comparison of verapamil and practolol in paroxysmal supraventricular tachycardia

22 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Effect of verapamil in infants with paroxysmal supraventricular tachycardia

22 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

22 August 2023

Q64860890

39

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Verapamil in the treatment of paroxysmal supraventricular tachycardia

22 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem

22 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

The clinical use of intravenous verapamil

22 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part I: Basic and Clinical Electrophysiologic Effects

22 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study

22 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Immediate Effects of Intravenous Verapamil in Cardiac Arrhythmias

22 August 2023

46

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Verapamil in atrial fibrillation and atrial flutter

22 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Verapamil plasma levels and ventricular rate response in patients with atrial fibrillation and flutter

22 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction

22 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study

22 August 2023

52

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Clinical results with verapamil in intravenous administration in the emergency therapy of cardiac arrhythmias

22 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Treatment of chronic atrial fibrillation in the elderly, assessed by ambulatory electrocardiographic monitoring

22 August 2023

56

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Effect of Oral Verapamil on Ventricular Irregularity in Long-Standing Atrial Fibrillation

22 August 2023

57

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Plasma digoxin concentrations in patients with atrial fibrillation and indications for the association with other antiarrhythmic agents

22 August 2023

58

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Haemodynamic effect of intravenous verapamil in controlled atrial fibrillation

22 August 2023

59

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Oral verapamil as maintenance therapy after cardioversion for atrial fibrillation

22 August 2023

60

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications

22 August 2023

62

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Verapamil associated with quinidine in the treatment of chronic atrial fibrillation

22 August 2023

65

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

22 August 2023

Asystole after verapamil

69

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Verapamil in cardiac arrhythmias

22 August 2023

71

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

Saturable metabolism of perhexiline maleate: Correlations with long-term toxicity

22 August 2023

74

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90025-1

22 August 2023

Identifiers

1 reference

17 September 2017

1 reference